The Smartinhaler system from New Zealand-based Adherium Ltd. connects with an app to monitor medication adherence, usage, and dosage.
Read more about ‘Smart’ Inhaler System Improves Patient Outcomes in Study
The National Institute for Clinical Excellence (NICE) has recognised digital platform Smartinhaler as the most effective means of improving asthma medication adherence in new guidance.
Read more about NICE recognises Smartinhaler as best practice for asthma care
Digital health technology company, Adherium Limited, has appointed Scott Fleming as Senior Vice President of Business Development, Europe with immediate effect. - link here
Business update call scheduled for today at 4:30 p.m. Eastern
AB-SA01 meets primary endpoints of safety and tolerability and reduces S. aureus bacterial load in all patients
Business update call scheduled for January 4, 2017 at 4:30 p.m. Eastern
SAN DIEGO--(BUSINESS WIRE)--AmpliPhi Biosciences Corporation (NYSEMKT:APHB), a biotechnology company focused on the discovery, development and commercialization of novel phage therapeutics, today announced the pricing of an underwritten public offering of...
Melbourne, Australia-based smart inhaler company Adherium has been selected to supply the technology for a multi-country research program in Europe that will seek to establish whether home monitoring and mobile...
Read more about Adherium's Smartinhaler selected for multisite study in EU
SAN DIEGO--(BUSINESS WIRE)--AmpliPhi Biosciences Corporation (NYSEMKT: APHB), a biotechnology company focused on the development and commercialization of novel bacteriophage-based antibacterial therapeutics, today announced financial results for the third quarter ended...
CEO Shareholder Letter and Quarterly Report Dear Shareholder, link here
Read more about Quarterly Report and Update from CEO